Evidence map›Paper›PMID 31065429›Full record

ArticleBiomedical optics express2018

On the spectral signature of melanoma: a non-parametric classification framework for cancer detection in hyperspectral imaging of melanocytic lesions.

Arturo Pardo, José A Gutiérrez-Gutiérrez, I Lihacova, José M López-Higuera, Olga M Conde

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Effects of dimension reduction of hyperspectral images in skin gross pathology.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Arturo PardoGrupo de Ingeniería Fotónica, TEISA, Universidad de Cantabria, Avenida Los Castros S/N, 39006, Cantabria, Spain.
José A Gutiérrez-GutiérrezGrupo de Ingeniería Fotónica, TEISA, Universidad de Cantabria, Avenida Los Castros S/N, 39006, Cantabria, Spain.
I LihacovaBiophotonics Laboratory, Institute of Atomic Physics and Spectroscopy, Raina Blvd. 19, Riga, LV-1586, Latvia.
José M López-HigueraGrupo de Ingeniería Fotónica, TEISA, Universidad de Cantabria, Avenida Los Castros S/N, 39006, Cantabria, Spain.
Olga M CondeGrupo de Ingeniería Fotónica, TEISA, Universidad de Cantabria, Avenida Los Castros S/N, 39006, Cantabria, Spain.
Universidad de Cantabria · ESUniversity of Latvia · LV

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early detection and diagnosis is a must in secondary prevention of melanoma and other cancerous lesions of the skin. In this work, we present an online, reservoir-based, non-parametric estimation and classification model that allows for this functionality on pigmented lesions, such that detection thresholding can be tuned to maximize accuracy and/or minimize overall false negative rates. This system has been tested in a dataset consisting of 116 patients and a total of 124 hyperspectral images of nevi, raised nevi and melanomas, detecting up to 100% of the suspicious lesions at the expense of some false positives.

Identifiers

PMID31065429
PMCPMC6491016
OpenAlexW2901580175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.